Your request to link to rcsb for BDBM17638


  • 3ADS: human ppargamma ligand-binding domain in complex with indomethacin (10.1038/EMBOJ.2010.197 )
  • 3ADX: human ppargamma ligand-binding domain in complex with indomethacin and nitro-233 (10.1038/EMBOJ.2010.197 )
  • 4YIA: structural mechanism of hormone release in thyroxine binding globulin
  • 1Z9H: microsomal prostaglandin e synthase type-2 (10.1016/J.JMB.2005.03.035 )
  • 4XUM: ppargamma ligand binding domain in complex with indomethacin (10.1621/NRS.13004 )
  • 2ZB8: crystal structure of human 15-ketoprostaglandin delta-13- reductase in complex with nadp and indomethacin (10.1016/J.STR.2008.09.007 )
  • 2BXK: human serum albumin complexed with myristate, azapropazone and indomethacin (10.1016/J.JMB.2005.07.075 )
  • 2BXM: human serum albumin complexed with myristate and indomethacin (10.1016/J.JMB.2005.07.075 )
  • 2BXQ: human serum albumin complexed with myristate, phenylbutazone and indomethacin (10.1016/J.JMB.2005.07.075 )
  • 3H1X: simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase a2 complexed with indomethacin at 1.4 a resolution reveals the presence of the new common ligand binding site (10.1002/JMR.960 )
  • 4COX: cyclooxygenase-2 (prostaglandin synthase-2) complexed with a non- selective inhibitor, indomethacin (10.1038/384644A0 )
  • 1S2A: crystal structures of prostaglandin d2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin (10.1158/0008-5472.CAN-03-2847 )
  • 4JQ4: akr1c2 complex with indomethacin
  • 2DM6: crystal structure of anti-configuration of indomethacin and leukotriene b4 12-hydroxydehydrogenase/15-oxo-prostaglandin 13- reductase complex (10.1093/JB/MVJ176 )
  • 3UGR: akr1c3 complex with indomethacin at ph 6.8 (10.1371/JOURNAL.PONE.0043965 )
  • 3UG8: akr1c3 complex with indomethacin at ph 7.5 (10.1371/JOURNAL.PONE.0043965 )
  • 3IB1: structural basis of the prevention of nsaid-induced damage of the gastrointestinal tract by c-terminal half (c-lobe) of bovine colostrum protein lactoferrin: binding and structural studies of c- lobe complex with indomethacin (10.1016/J.BPJ.2009.09.030 )
  • 4KYK: crystal structure of mouse glyoxalase i complexed with indomethacin (10.1002/CMDC.201300243 )
  • 4IKI: crystal structure of wild-type human transthyretin in complex with indomethacin
  • 4IK7: crystal structure of human transthyretin in complex with indomethacin
  • 2OTH: crystal structure of a ternary complex of phospholipase a2 with indomethacin and nimesulide at 2.9 a resolution
  • 3FO7: simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase a2 complexed with indomethacin at 1.4 a resolution reveals the presence of the new common ligand binding site
  • 4EIX: structural studies of the ternary complex of phaspholipase a2 with nimesulide and indomethacin